Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 14Prostatic Neoplasms 13Colorectal Neoplasms 13Neoplasms 12Pancreatic Neoplasms 10Endometrial Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Breast Neoplasms 9Lung Neoplasms 7Colonic Neoplasms 7Neoplasm Metastasis 6Carcinoma, Hepatocellular 6Oropharyngeal Neoplasms 5Multiple Myeloma 5Mouth Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Sarcoma 4Recurrence 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Esophageal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Melanoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Head and Neck Neoplasms 3Gastrointestinal Stromal Tumors 3

Interventions

Cisplatin 86Radiotherapy 71Paclitaxel 50Fluorouracil 38Carboplatin 36Drug Therapy 32Neoadjuvant Therapy 23toripalimab 19tislelizumab 18pembrolizumab 17camrelizumab 17Irinotecan 17Esophagectomy 17Surgical Procedures, Operative 16Radiation 16Docetaxel 16sintilimab 15Oxaliplatin 14130-nm albumin-bound paclitaxel 14nimotuzumab 11TP protocol 11S 1 (combination) 11Radiotherapy, Intensity-Modulated 11Cetuximab 11Capecitabine 11Albumin-Bound Paclitaxel 10apatinib 9Leucovorin 9Immune Checkpoint Inhibitors 8nedaplatin 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Esophageal Squamous Cell Carcinoma × Observation × Clear all
NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Sichuan University

Phase NA Not yet recruiting
98 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡